A recent study suggests that a drug approved for the treatment of seizures may also help treat Alzheimer's in people who do ...
Seltorexant is one of J&J’s most promising neuroscience candidates. The human orexin-2 receptor selective agonist produced ...
"The results fundamentally alter scientists' understanding of how Alzheimer's harms the brain," researchers say.
A new study finds that it's not just about how much HDL a woman has — it's about the quality of those tiny, fat-carrying ...
Scientist Michel Brahic's new book delves into the world of prions, the culprits behind some of the scariest illnesses around ...
Researchers from the Massachusetts Institute of Technology (MIT) have discovered that Alzheimer's disease destroys the brain ...
Alzamend Neuro Announces Full Data Set from Phase IIA Multiple Ascending Dose Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s ...
Each year, about 2.5 million people suffer from traumatic brain injuries (TBI), which often increases their risk of ...
Cognito Therapeutics today announced a publication demonstrating structural brain preservation with its Spectris treatment.
Alzheimer’s Disease May Damage the Brain in Two Phases - NIH Study Uncovers Which Cell Types May Be Harmed First ...
From diabetes, heart disease, kidney illness to sickle cell anemia, and even Alzheimer's disease, could be detected early ...
On Wednesday, Alzamend Neuro, Inc. (NASDAQ:ALZN) said it received the final full data set from its multiple ascending dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback